Operating Lease, Right-of-Use Asset of CHINA PHARMA HOLDINGS, INC. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
CHINA PHARMA HOLDINGS, INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • CHINA PHARMA HOLDINGS, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $197,851, a 236% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

CHINA PHARMA HOLDINGS, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $197,851 +$138,920 +236% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q1 2025 $19,176 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $38,298 -$78,312 -67% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $58,931 -$75,274 -56% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $77,259 -$75,142 -49% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q4 2023 $116,610 +$77,564 +199% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $134,205 +$76,751 +134% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $152,401 +$71,362 +88% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $19,787 -$87,307 -82% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $39,046 -$88,912 -69% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $57,454 -$89,305 -61% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $81,039 -$88,768 -52% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $107,094 +$81,725 +322% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $127,958 +$78,271 +158% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $146,759 +$76,026 +107% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $169,807 +$79,518 +88% 30 Jun 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 $25,369 -$87,078 -77% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 $49,687 -$87,092 -64% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q3 2020 $70,733 -$86,444 -55% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 $90,289 -$94,329 -51% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 $112,447 -$100,140 -47% 31 Mar 2020 10-Q 14 May 2020 2020 Q1
Q4 2019 $136,779 31 Dec 2019 10-K 26 Mar 2021 2020 FY
Q3 2019 $157,177 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $184,618 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $212,587 31 Mar 2019 10-Q 14 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.